Hermetica Superfood Encyclopedia
The Short Answer
Aloe macrocarpa leaf latex contains anthraquinone glycosides—primarily aloin A and aloin B—that demonstrate antileishmanial, pro-apoptotic, and dual antioxidant-prooxidant activities through modulation of redox signaling and cell cycle arrest pathways. In vitro evidence indicates its latex-derived aloe-emodin achieves an IC50 of approximately 40 μg/mL against Leishmania major amastigotes, though no human clinical trials have yet validated these effects.
CategoryHerb
GroupAfrican
Evidence LevelPreliminary
Primary KeywordAloe macrocarpa benefits
Aloe macrocarpa — botanical close-up
Health Benefits
**Antileishmanial Activity**
Latex-derived anthraquinones, particularly aloin A/B and their semisynthetic derivative aloe-emodin, have demonstrated activity against Leishmania major amastigotes in vitro, with aloe-emodin achieving an IC50 of ~40 μg/mL, suggesting potential utility in parasitic infection management pending further investigation.
**Anticancer Potential**
Aloin A and aloin B from Aloe genus species induce cell cycle arrest and trigger apoptosis across multiple cancer cell lines, including breast, ovarian, uterine carcinoma, melanoma, and colorectal cancer models, though no A. macrocarpa-specific human data yet exists.
**Antioxidant Defense**
Anthraquinone derivatives from the leaf latex, including aloe-emodin, exhibit concentration-dependent antioxidant activity by scavenging reactive oxygen species (ROS), with high-concentration emodin acting as a net antioxidant by donating electrons to free radicals.
**Wound Healing Support**
In Malagasy traditional medicine, leaf gel and latex are applied topically to wounds and skin lesions, consistent with genus-wide evidence that aloe polysaccharides and anthraquinones promote fibroblast proliferation and reduce oxidative stress at wound sites.
**Anti-inflammatory Properties**
Aloe anthraquinones, including aloe-emodin, inhibit pro-inflammatory mediators such as arachidonic acid-derived eicosanoids by suppressing cyclooxygenase activity, a mechanism extrapolated from related Aloe species and applicable to A. macrocarpa pending species-specific confirmation.
**Antimicrobial Activity**
Aloin and aloe-emodin exhibit broad-spectrum antimicrobial properties against gram-positive and gram-negative bacteria in in vitro models across the Aloe genus, consistent with the traditional use of A. macrocarpa latex in managing infected wounds in Madagascar.
**Pro-oxidant Cytotoxic Activity**
At low concentrations, aloin and emodin derivatives act as pro-oxidants, generating ROS that selectively damage cancer cell mitochondria, a dual redox role that may underpin their cytotoxic selectivity toward rapidly dividing malignant cells.
Origin & History
Natural habitat
Aloe macrocarpa is native to eastern Africa and the island of Madagascar, where it grows in semi-arid savanna and rocky hillside habitats at varying elevations. Like most aloes, it thrives in well-drained, sandy or rocky soils with low rainfall and high solar exposure, adaptations common to succulent xerophytes. The species has been documented in Malagasy ethnobotanical traditions, where local communities harvest its leaves for wound care and topical medicinal applications.
“Aloe macrocarpa occupies a place within the rich ethnobotanical heritage of Madagascar, where diverse Aloe species have been integrated into traditional Malagasy healing systems for generations, particularly for the treatment of wounds, burns, and skin conditions through topical latex or gel application. The broader genus Aloe has been documented in African and Indian Ocean island traditional medicine systems for over two thousand years, with uses ranging from wound healing and anti-inflammatory poultices to purgative preparations from the bitter latex fraction. In Malagasy practice, the harvesting of aloe leaves typically involves severing basal leaves close to the stem and allowing the yellow latex to drain before applying the inner clear gel to affected areas, a preparation method consistent with pan-African aloe ethnomedicine. Formal ethnobotanical documentation of A. macrocarpa's specific traditional indications, preparation rituals, and cultural significance remains sparse in the peer-reviewed literature, representing an important gap for future ethnopharmacological fieldwork in Madagascar.”Traditional Medicine
Scientific Research
The scientific evidence base for Aloe macrocarpa is extremely limited and confined almost entirely to in vitro phytochemical and pharmacological studies, with no published clinical trials or animal model investigations specific to this species as of the available literature. Phytochemical characterization has been conducted using thin-layer chromatography (TLC) and co-TLC with reference standards to identify aloin A/B, their p-coumaroyl esters, O-rhamnosides (microdontin A/B), and aloinoside A/B in the leaf latex. Antileishmanial bioactivity has been assessed in vitro against Leishmania major amastigote models, where aloe-emodin derived from A. macrocarpa latex demonstrated an IC50 of approximately 40 μg/mL, though no quantified IC50 values for crude latex or intact aloin glycosides from this species have been independently reported. Extrapolation from Aloe vera and Aloe ferox research—where anthraquinone content can reach up to 30% of dry leaf material and acemannan polysaccharides demonstrate immunomodulatory effects—provides contextual mechanistic scaffolding, but direct translation to A. macrocarpa requires species-specific validation.
Preparation & Dosage
Traditional preparation
**Traditional Topical Application (Leaf Gel/Latex)**
Fresh leaf latex or gel applied directly to wounds and skin lesions as practiced in Malagasy ethnomedicine; no standardized preparation protocol or application frequency is formally documented for this species.
**Crude Leaf Latex Extract**
Laboratory preparations involve direct latex collection from cut leaves followed by air-drying or lyophilization; no standardized extract with defined anthraquinone content exists commercially for A. macrocarpa.
**TLC-Fractionated Aloin A/B Isolates**
Research-grade isolation uses silica gel TLC and acid hydrolysis to yield aloin A/B and aloe-emodin for bioassay; these are not available as consumer supplements.
**Semisynthetic Aloe-Emodin Derivatives**
Aloin A/B can be chemically converted to aloe-emodin and rhein via controlled acid hydrolysis for research applications; effective concentrations in vitro range approximately 10–100 μg/mL depending on the target organism.
**No Established Oral Supplement Dose**
50–200 mL/day of stabilized gel, but direct extrapolation to A
No clinically validated oral dosage has been established for A. macrocarpa; by genus analogy, Aloe vera oral gel preparations are typically used at . macrocarpa is not supported by evidence.
**Standardization**
No commercial standardization for aloin content, aloe-emodin concentration, or polysaccharide fraction exists specifically for A. macrocarpa.
Nutritional Profile
Aloe macrocarpa has not been subjected to formal nutritional compositional analysis, and no macronutrient, micronutrient, or phytochemical concentration data has been published specifically for this species. Based on genus Aloe norms, the inner leaf gel of related species contains approximately 98–99% water, with the dry matter comprising polysaccharides (notably acemannan, MW 4–7 million Daltons in A. vera), free sugars (glucose, fructose), amino acids, vitamins (C, E, B12 traces), and minerals (calcium, magnesium, potassium). The leaf latex fraction, most studied in A. macrocarpa, is dominated by anthraquinone glycosides (aloin A/B and derivatives), with related species such as Aloe ferox containing anthraquinones at up to 30% of dried latex material; specific concentrations for A. macrocarpa remain unquantified. Bioavailability of anthraquinone glycosides like aloin is influenced by gut microbiota-mediated hydrolysis to active aglycones, with hepatic first-pass metabolism further modifying systemic exposure, though no pharmacokinetic data exists for A. macrocarpa-specific compounds.
How It Works
Mechanism of Action
The primary bioactives in Aloe macrocarpa leaf latex are aloin A and aloin B (C-glycosidic anthraquinones), which undergo acid hydrolysis or metabolic conversion to yield aloe-emodin and rhein—bioactive aglycones with distinct pharmacological targets. Aloe-emodin inhibits topoisomerase II and disrupts mitochondrial membrane potential in cancer cells, triggering caspase-dependent apoptosis and G2/M phase cell cycle arrest by downregulating cyclin B1 expression. In Leishmania parasites, aloe-emodin's antileishmanial mechanism is hypothesized to involve disruption of the parasite's redox homeostasis and inhibition of trypanothione reductase, an enzyme critical to the parasite's defense against oxidative stress and absent in mammalian hosts. Emodin and aloin also modulate NF-κB signaling at varying concentrations—exhibiting antioxidant hydrogen-donating capacity at high doses while generating superoxide radicals via semiquinone intermediates at low doses, a concentration-dependent dual redox behavior that influences both anti-inflammatory and cytotoxic outcomes.
Clinical Evidence
No clinical trials have been conducted specifically on Aloe macrocarpa in human subjects, making it impossible to draw clinically validated conclusions regarding efficacy, optimal dosing, or therapeutic safety in any disease indication. The sole quantified pharmacological outcome reported for this species is an in vitro IC50 of ~40 μg/mL for aloe-emodin against Leishmania major amastigotes, a preliminary finding that establishes biological plausibility but does not constitute clinical evidence. Anticancer and antioxidant effects attributed to aloin A/B are supported by in vitro data from related Aloe species, but without A. macrocarpa-specific cell line studies or pharmacokinetic profiling, effect sizes and therapeutic windows remain undefined. Confidence in clinical outcomes is accordingly very low, and any therapeutic application of A. macrocarpa should be regarded as exploratory and hypothesis-generating rather than evidence-based.
Safety & Interactions
Safety data specific to Aloe macrocarpa has not been formally evaluated in toxicological studies, animal models, or human trials, making it impossible to define a safe dose range or confirm the absence of acute or chronic toxicity for this species. By analogy with other anthraquinone-containing Aloe species, oral ingestion of aloin-rich latex carries known risks including stimulant laxative effects, electrolyte imbalance (hypokalemia), and abdominal cramping, particularly with repeated or high-dose use; the European Medicines Agency has noted concerns about genotoxic and carcinogenic potential of hydroxyanthracene-containing preparations at high doses. Aloe anthraquinones may potentiate the effects of cardiac glycosides (e.g., digoxin) by inducing hypokalemia, may interact with diuretics by compounding electrolyte loss, and could theoretically enhance the effects of anticoagulants; no A. macrocarpa-specific drug interaction data exists. Topical use of leaf gel is generally considered low-risk based on genus-wide precedent, but oral ingestion of the latex fraction should be avoided during pregnancy (due to potential uterotonic anthraquinone activity), during lactation, and in individuals with inflammatory bowel disease or renal insufficiency until species-specific safety data is available.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Aloe macrocarpa Todd.Large-fruited aloeMalagasy medicinal aloeA. macrocarpa
Frequently Asked Questions
What is Aloe macrocarpa used for traditionally?
In Malagasy traditional medicine, Aloe macrocarpa is primarily used for wound healing and topical skin treatment, with fresh leaf latex or gel applied directly to cuts, burns, and skin lesions. This use is consistent with broader pan-African ethnomedicinal traditions for Aloe species, though formal ethnobotanical documentation specific to A. macrocarpa remains limited in the scientific literature.
What active compounds are found in Aloe macrocarpa?
The leaf latex of Aloe macrocarpa contains aloin A and aloin B as primary C-glycosidic anthraquinones, along with their p-coumaroyl esters, O-rhamnosides (microdontin A and B), and aloinoside A/B. Acid hydrolysis of these glycosides yields the bioactive aglycones aloe-emodin and rhein, which are responsible for the species' documented antileishmanial and cytotoxic activities in laboratory studies.
Is Aloe macrocarpa effective against Leishmania infection?
In vitro studies have shown that aloe-emodin, a derivative of aloin A/B isolated from Aloe species including A. macrocarpa, achieves an IC50 of approximately 40 μg/mL against Leishmania major amastigotes in cell culture models. However, no animal studies or human clinical trials have been conducted with A. macrocarpa specifically, so its real-world antileishmanial efficacy in living organisms remains unproven and requires significant further research.
Are there any safety concerns or side effects with Aloe macrocarpa?
No formal toxicological assessment has been published for Aloe macrocarpa, but by analogy with other anthraquinone-rich aloes, oral ingestion of the latex fraction poses risks including stimulant laxative effects, hypokalemia, and potential interaction with cardiac glycosides like digoxin or diuretics. Oral consumption of the latex fraction is not recommended during pregnancy due to the potential uterotonic effects of anthraquinone compounds, and topical application remains the only historically documented and relatively lower-risk route of use.
How does Aloe macrocarpa compare to Aloe vera?
Aloe macrocarpa shares the anthraquinone-rich latex composition characteristic of the Aloe genus, including aloin A/B compounds also found in Aloe vera, but lacks the extensive clinical trial database that supports Aloe vera's use in wound healing, constipation, and blood sugar management. Aloe vera's inner gel is rich in acemannan polysaccharides (MW 4–7 million Daltons) with well-documented immunomodulatory effects, whereas A. macrocarpa's gel composition and polysaccharide profile remain uncharacterized, making direct therapeutic comparisons premature.
What is the most bioavailable form of Aloe macrocarpa for antileishmanial benefits?
Aloe macrocarpa latex extracts containing anthraquinones (aloin A/B and aloe-emodin) demonstrate the strongest in vitro activity against Leishmania parasites. Semisynthetic derivatives like aloe-emodin show superior bioavailability compared to raw latex, with aloe-emodin achieving measurable IC50 values around 40 μg/mL in laboratory studies. However, clinical bioavailability data in humans remains limited, and formulation stability affects anthraquinone preservation during processing and storage.
Is Aloe macrocarpa safe to take with antimalarial or antiparasitic medications?
Limited clinical data exists on drug interactions between Aloe macrocarpa and antimalarial or antiparasitic medications, though its anthraquinone content may theoretically interact with medications metabolized through similar pathways. The latex form contains potent compounds (aloin, aloe-emodin) that have cathartic properties and could potentially interfere with drug absorption if taken simultaneously. Consultation with a healthcare provider is essential before combining Aloe macrocarpa supplements with prescription antiparasitic treatments to avoid reduced efficacy or adverse effects.
How strong is the clinical evidence supporting Aloe macrocarpa for parasitic infections compared to laboratory findings?
While in vitro studies show promising antileishmanial activity from Aloe macrocarpa's aloe-emodin and aloin compounds, robust human clinical trials remain absent and evidence strength is currently limited to laboratory data. Most supporting research involves isolated anthraquinone compounds rather than whole-plant extracts, creating a gap between bench research and real-world efficacy. Further investigation through controlled clinical trials in infected human populations is necessary before Aloe macrocarpa can be considered an established therapeutic option for parasitic infections.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w aloe-macrocarpa-aloe-macrocarpa-todd curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
